290 related articles for article (PubMed ID: 11229866)
1. Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.
Kontoyiannis DP; Andersson BS; Lewis RE; Raad II
Clin Infect Dis; 2001 Mar; 32(5):E94-6. PubMed ID: 11229866
[TBL] [Abstract][Full Text] [Related]
2. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
[TBL] [Abstract][Full Text] [Related]
3. Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease.
Roy V; Ali LI; Carter TH; Selby GB
J Infect; 2000 Nov; 41(3):273-5. PubMed ID: 11120619
[TBL] [Abstract][Full Text] [Related]
4. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
[TBL] [Abstract][Full Text] [Related]
5. [Curative treatment of invasive aspergillosis].
Dupont B
Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
[TBL] [Abstract][Full Text] [Related]
6. Disseminated invasive aspergillosis in an apparently immunocompetent host.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation.
Catalano L; Fontana R; Scarpato N; Picardi M; Rocco S; Rotoli B
Haematologica; 1997; 82(1):71-2. PubMed ID: 9107088
[TBL] [Abstract][Full Text] [Related]
8. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
9. Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Klein KC; Blackwood RA
Pediatrics; 2006 Aug; 118(2):e506-8. PubMed ID: 16816005
[TBL] [Abstract][Full Text] [Related]
10. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
11. Resolution of invasive central nervous system aspergillosis in a transplant recipient.
Khoury H; Adkins D; Miller G; Goodnough L; Brown R; DiPersio J
Bone Marrow Transplant; 1997 Jul; 20(2):179-80. PubMed ID: 9244425
[TBL] [Abstract][Full Text] [Related]
12. Invasive subglottal aspergillosis in a patient with severe aplastic anemia: a case report.
Nagasawa M; Itoh S; Tomizawa D; Kajiwara M; Sugimoto T; Kumagai J
J Infect; 2002 Apr; 44(3):198-201. PubMed ID: 12099752
[TBL] [Abstract][Full Text] [Related]
13. [Remission of invasive sinusal and pulmonary aspergillosis with liposomal amphotericin B in a patient with chronic lymphatic leukemia following failure with conventional amphotericin].
Palacio C; Acebedo G; López A; Jodar JM
Sangre (Barc); 1994 Oct; 39(5):389-92. PubMed ID: 7754445
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
Ito JI; Chandrasekar PH; Hooshmand-Rad R
Bone Marrow Transplant; 2005 Nov; 36(10):873-7. PubMed ID: 16113663
[TBL] [Abstract][Full Text] [Related]
15. Aspergillus-induced discitis. A role for itraconazole in therapy?
McGregor A; McNicol D; Collignon P
Spine (Phila Pa 1976); 1992 Dec; 17(12):1512-4. PubMed ID: 1335170
[No Abstract] [Full Text] [Related]
16. Urinary tract aspergillosis in a renal transplant recipient.
Shirwany A; Sargent SJ; Dmochowski RR; Bronze MS
Clin Infect Dis; 1998 Nov; 27(5):1336. PubMed ID: 9827304
[No Abstract] [Full Text] [Related]
17. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
Paterson PJ; Seaton S; Prentice HG; Kibbler CC
J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant itraconazole in the treatment of destructive sphenoid aspergillosis.
Rowe-Jones JM; Freedman AR
Rhinology; 1994 Dec; 32(4):203-7. PubMed ID: 7701229
[TBL] [Abstract][Full Text] [Related]
19. [Invasive bronchopulmonary aspergillosis treated with itraconazole in a patient with acute leukemia].
Sarcía-Ruiz JC; Alvarez C; Floristán F; Hernández I; Hernández J; Alvarez Blanco A; Ponton J
Sangre (Barc); 1993 Oct; 38(5):399-402. PubMed ID: 8140504
[TBL] [Abstract][Full Text] [Related]
20. Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.
Linden PK; Coley K; Fontes P; Fung JJ; Kusne S
Clin Infect Dis; 2003 Jul; 37(1):17-25. PubMed ID: 12830404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]